Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC    

Global Antiinfectives for Systemic Use Market Research Report

PRODUCT TITLE PUBLISHED
Global Inactivated Vaccines Market Global Inactivated Vaccines Market
The Global Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $1958 million in 2013 and expected to be $2974million by 2018 at a CAGR of 8.7%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Sub-unit Vaccines Market Global Sub-unit Vaccines Market
The Global Subunit Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $91 million in 2013 and expected to be $134 million by 2018 at a CAGR of 8.1%. Subunit Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Toxoid Vaccines Market Global Toxoid Vaccines Market
The Global Toxoid Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $468.1 million in 2013 and expected to be $644.8 million by 2018 at a CAGR of 6.6%. Toxoid Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Conjugate Vaccines Market Global Conjugate Vaccines Market
The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Global Recombinant Vaccines Market Global Recombinant Vaccines Market
The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Dna Vaccines Market Global Dna Vaccines Market
The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Animal Vaccines Animal Vaccines
Animal Vaccines and Bacterial vaccines, Viral vaccines,
Upcoming
Synthetic Vaccines Synthetic Vaccines
Synthetic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Dentritic Vaccines Dentritic Vaccines
Dentritic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Antimycobacterial Aminosalicylic acid and derivatives Antimycobacterial Aminosalicylic acid and derivatives
Antimycobacterial Aminosalicylic acid and derivatives and its peer markets - E-Clinical Trial Solutions,
Upcoming
Antimycobacterial Antibiotics Antimycobacterial Antibiotics
Antimycobacterial Antibiotics and its peer markets - Combinations of drugs for treatment of tuberculosis, E-Clinical Trial Solutions,
Upcoming
Antimycobacterial Hydrazides Antimycobacterial Hydrazides
Antimycobacterial Hydrazides and its peer markets - Proteomics,
Upcoming
Antimycobacterial Thiocarbamide derivatives Antimycobacterial Thiocarbamide derivatives
Antimycobacterial Thiocarbamide derivatives and its peer markets - E-Clinical Trial Solutions,
Upcoming
Canine Vaccines Canine Vaccines
Canine Vaccines and Feline Vaccines adds up to total Companion animal vaccines market. Canine Vaccines can be segmented by Types, Geographies,...
Upcoming
Feline Vaccines Feline Vaccines
Feline Vaccines and Canine Vaccines adds up to total Companion animal vaccines market. Feline Vaccines can be segmented by Types, Geographies,...
Upcoming
Bovine Vaccines Bovine Vaccines
Bovine Vaccines and Small Ruminant Vaccines adds up to total Livestock market. Bovine Vaccines can be segmented by Types, Geographies,...
Upcoming
Small Ruminant Vaccines Small Ruminant Vaccines
Small Ruminant Vaccines and Bovine Vaccines adds up to total Livestock market. Small Ruminant Vaccines can be segmented by Types, Geographies,...
Upcoming
Infectious Bronchitis Infectious Bronchitis
Infectious Bronchitis and Gumboro Disease, Avian Influenza,
Upcoming
Gumboro Disease Gumboro Disease
Gumboro Disease and Infectious Bronchitis, Avian Influenza,...
Upcoming
Avian Influenza Avian Influenza
Avian Influenza and Infectious Bronchitis, Gumboro Disease,...
Upcoming
75 reports | Show
Connect With Us
US/CAN : +1-888-502-0539